CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)	3 Months Ended	9 Months Ended
	Sep. 30, 2019 USD ($)	Sep. 30, 2019 USD ($)	Sep. 30, 2018 USD ($)
Cash flows from operating activities
Net loss	$ (1,158,883)	$ (6,857,643)	$ (1,940,129)
Adjustments to reconcile net loss to cash provided by (used in) operating activities
Stock based compensation expense		473,491	494,779
Depreciation and amortization		5,333,485	5,234,014
Gain on sale of assets	0	(31,443)	(51,523)
Contingent consideration reduction		(15,564)	0
Reduction in allowance for bad debt		(389,943)	0
(Decrease) increase in fair value of derivative warrant liability		(331,715)	2,124,971
Loss on commodity derivative contracts	1,622,056	2,691,833	1,859,234
Net cash settlements on commodity derivatives		(3,446,274)	(2,386,897)
Amortization of debt discount and deferred costs		430,431	474,360
Changes in operating assets and liabilities
Accounts receivable		(987,778)	(3,091,273)
Inventory		2,212,989	(341,329)
Prepaid expenses		(833,485)	(1,072,076)
Accounts payable		(1,046,149)	534,689
Accrued expenses		(260,341)	(1,175,692)
Other assets		0	(253,642)
Net cash (used in) provided by operating activities		(3,058,106)	409,486
Cash flows from investing activities
Acquisition of SES		0	(269,826)
Internally developed software		(380,216)	0
Purchase of fixed assets		(2,907,330)	(1,813,904)
Proceeds from sale of fixed assets		86,846	6,848
Net cash used in investing activities		(3,200,700)	(2,076,882)
Cash flows from financing activities
Payments on finance leases		(113,241)
Payments on finance leases			(34,660)
Proceeds from exercise of stock options		7,075	0
Distribution VRM LA		(285,534)	0
Contributions received from redeemable noncontrolling interest	3,150,000	3,150,000	0
Proceeds received from issuance of common stock and warrants		2,216,711	0
Line of credit (payments) proceeds, net		1,543,003	1,408,206
Proceeds from note payable		2,809,139	4,024,964
Payments on note payable		(3,514,365)	(2,996,556)
Net cash provided by financing activities		5,812,788	2,401,954
Net change in cash, cash equivalents and restricted cash		(446,018)	734,558
Cash, cash equivalents, and restricted cash at beginning of the period		2,849,831	1,105,787
Cash, cash equivalents, and restricted cash at end of period	2,403,813	2,403,813	1,840,345
SUPPLEMENTAL INFORMATION
Cash paid for interest		1,887,012	2,034,275
Cash paid for taxes		0	0
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Accretion of discount on Series B and B1 Preferred Stock	550,774	1,644,374	2,351,472
Dividends-in-kind accrued on Series B and B1 Preferred Stock	1,238,766	1,238,766	2,284,121
Equipment acquired under finance leases		621,000	450,098
Initial adjustment of carrying amount redeemable noncontrolling interest	970,809	970,809	0
Accretion of redeemable noncontrolling interest to redemption value	1,849,930	1,849,930	0
Series A Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Preferred Stock into common stock		0	34
Series B Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Preferred Stock into common stock		0	99,629
Dividends-in-kind accrued on Series B and B1 Preferred Stock	175,305	175,305
Series B1 Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Preferred Stock into common stock		149,914	$ 4,614,354
Dividends-in-kind accrued on Series B and B1 Preferred Stock	$ 243,777	$ 243,777